Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Bimekizumab effectively treated a man's chronic beard hair loss.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Rituximab can cause skin issues, but baricitinib may help improve them.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Baricitinib is effective as a treatment for severe hair loss.

Entospletinib effectively prevents eye and skin GVHD in mice.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.